What is Johnson & Johnson's remicade — percent change (as a percent)?

Johnson & Johnson (JNJ) reported remicade — percent change (as a percent) of 16.6% in Q3 2025.

How has Johnson & Johnson's remicade — percent change (as a percent) changed year-over-year?

Johnson & Johnson's remicade — percent change (as a percent) increased by 130.2% year-over-year, from -54.9% to 16.6%.

What does remicade — percent change (as a percent) mean?

The percentage growth or decline in sales revenue for the Remicade product compared to the previous period.

Remicade — Percent Change (as a percent)

Products & Services · Percent Change (as a percent)

Johnson & Johnson Remicade — Percent Change (as a percent) decreased by 62.6% to 16.6% in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 130.2%, from -54.9% to 16.6%. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment

CategoryGrowth

SignalHigher is better

VolatilityVolatile

First reportedQ1 2018

Last reportedQ3 2025

How to read this metric

A positive percentage indicates growth or resilience, whereas a negative percentage highlights accelerating revenue decline and the impact of market competition.

Detailed definition

This metric measures the period-over-period percentage growth or decline in net sales for the Remicade product line. It...

Peer comparison

Comparable to year-over-year or sequential growth rate metrics for individual pharmaceutical products or therapeutic franchises across the industry.

Metric ID: jnj_segment_remicade_percent_change_as_a_percent

Historical Data

14 periods

	Q2 '21	Q3 '21	Q4 '21	Q2 '22	Q3 '22	Q4 '22	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25
Value	-101%	-21.8%	-69.7%	-3.6%	-124.8%	-98.3%	-122.5%	-60.4%	-64.7%	-40.3%	-54.9%	-37.3%	44.4%	16.6%
QoQ Change	—	+78.4%	-219.7%	+94.8%	<-999%	+21.2%	-24.6%	+50.7%	-7.1%	+37.7%	-36.2%	+32.1%	+219.0%	-62.6%
YoY Change	—	—	—	+96.4%	-472.5%	-41.0%	<-999%	+51.6%	—	+67.1%	+9.1%	+42.3%	+210.2%	+130.2%

Range-124.8% – 44.4%

CAGR-42.6%

Avg YoY Growth-320.9%

Median YoY Growth+47.0%

Similar Metrics at Other Companies

Eli LillyLLY View metric

Frequently Asked Questions

What is Johnson & Johnson's remicade — percent change (as a percent)?: Johnson & Johnson (JNJ) reported remicade — percent change (as a percent) of 16.6% in Q3 2025.
How has Johnson & Johnson's remicade — percent change (as a percent) changed year-over-year?: Johnson & Johnson's remicade — percent change (as a percent) increased by 130.2% year-over-year, from -54.9% to 16.6%.
What does remicade — percent change (as a percent) mean?: The percentage growth or decline in sales revenue for the Remicade product compared to the previous period.